AffiliationMedical Oncology, Paterson Institute for Cancer Research, Wilmslow Road, Withington, Manchester M20 4BX, UK.
MetadataShow full item record
AbstractThe aim of this study was to construct a fusion protein from the cytokine granulocyte/macrophage colony-stimulating factor (GM-CSF) and a single-chain Fv fragment (scFv D29) and to investigate its potential to activate cells of the immune system against neuroblastoma cells expressing neural cell adhesion molecule (NCAM). Mammalian cell expression of the scFv D29-GM-CSF fusion protein was compared using a number of vectors, including retroviral and adenoviral vectors. The resultant fusion protein, expressed by HeLa cells, was found by ELISA to bind immobilized recombinant NCAM. Moreover, FACS analysis confirmed binding to the human neuroblastoma cell line SKNBE and a murine neuroblastoma cell line engineered to express the glycosylphosphatidylinositol form of human NCAM (N2A-rKNIE). The fusion protein was also found to stimulate the proliferation of the FDC-P1 haemopoietic cell line, which is dependent on GM-CSF (or interleukin 3) for continued growth. In vitro clonogenic assays indicated that scFv-GM-CSF could selectively induce growth inhibition of SKNBE cells by murine lymphoid cells.
CitationTargeted cytokine delivery to neuroblastoma. 2002, 30 (4):518-20 Biochem. Soc. Trans.
JournalBiochemical Society Transactions
- Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
- Authors: Stagg J, Wu JH, Bouganim N, Galipeau J
- Issue date: 2004 Dec 15
- Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins.
- Authors: Whittington HA, Ashworth LJ, Hawkins RE
- Issue date: 1998 Jun
- The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
- Authors: Batova A, Kamps A, Gillies SD, Reisfeld RA, Yu AL
- Issue date: 1999 Dec
- Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
- Authors: Xiang J
- Issue date: 1999
- Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities.
- Authors: Dreier T, Lode HN, Xiang R, Dolman CS, Reisfeld RA, Kang AS
- Issue date: 1998 Jul-Aug